Nationwide Fund Advisors’s Dr. Reddy's Laboratories RDY Stock Holding History

Nationwide Fund Advisors’s Portfolio RDY Stock Details RDY Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2016 Q3	–	Sell	-75,500	Closed	-$774K	–	3242
2016 Q2	$774K	Sell	75,500 -23,500	-24%	-$215K	﹤0.01%	1894
2016 Q1	$719K	Buy	99,000 +88,500	+843%	+$791K	﹤0.01%	1886
2015 Q4	$97K	Sell	10,500 -210,000	-95%	-$2.3M	﹤0.01%	2863
2015 Q3	$2.82M	Buy	220,500 +145,500	+194%	+$1.81M	0.01%	1199
2015 Q2	$830K	Buy	75,000 +55,000	+275%	+$607K	﹤0.01%	1965
2015 Q1	$228K	Sell	20,000 -105,000	-84%	-$1.11M	﹤0.01%	2629
2014 Q4	$1.26M	Hold	125,000	–	–	0.01%	1689
2014 Q3	$1.31M	Hold	125,000	–	–	0.01%	1688
2014 Q2	$1.08M	Buy	125,000 +50,000	+67%	+$420K	﹤0.01%	1815
2014 Q1	$659K	Buy	+75,000	New	+$652K	﹤0.01%	1928

Other funds holding RDY

Fisher Asset Management Camas, Washington $336B AUM 34.66% 1-Year Est. Return

CBOA

Commonwealth Bank of Australia Sydney, NSW, Australia $355M AUM

AQR Capital Management Greenwich, Connecticut $287B AUM 42.33% 1-Year Est. Return

Royal Bank of Canada Toronto, Ontario, Canada $672B AUM 33.48% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

VAM

Vontobel Asset Management New York $18.1B AUM 28.09% 1-Year Est. Return

BlackRock Group London, United Kingdom $210B AUM 15.5% 1-Year Est. Return

Dimensional Fund Advisors Austin, Texas $552B AUM 44.19% 1-Year Est. Return

Northern Trust Chicago, Illinois $860B AUM 41.15% 1-Year Est. Return

State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return

Nationwide Fund Advisors's RDY Position: Q3 2016 in Review

Nationwide Fund Advisors sold out of Dr. Reddy's Laboratories (RDY) in Q3 2016, closing a stake of 75,500 shares — an estimated $774K sold.

Nationwide Fund Advisors first reported a position in RDY in Q1 2014 and held it in 10 quarters. The position peaked at $2.82M in Q3 2015. 157 funds tracked by Wall St. Rank hold RDY as of Q3 2016.

Nationwide Fund Advisors reported no remaining Dr. Reddy's Laboratories position as of Q3 2016 after selling out during the quarter.
Nationwide Fund Advisors sold 75,500 Dr. Reddy's Laboratories shares in Q3 2016, an estimated $774K.
Nationwide Fund Advisors first reported a position in Dr. Reddy's Laboratories in Q1 2014 and held it in 10 quarters.
Nationwide Fund Advisors's Dr. Reddy's Laboratories position peaked at $2.82M in Q3 2015.
157 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q3 2016.

Based on Nationwide Fund Advisors's 13F filing for Q3 2016, filed 20 Oct 2016.